Tag: Allergies: Misc.
Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Guidance relates to risks for allergic reactions for mRNA (Moderna and Pfizer) and adenovirus vector (Johnson & Johnson) COVID-19 vaccines
One in Five Allergy/Asthma Patients Report Cannabis Use
Among cannabis users, half of those with asthma report smoking cannabis
Pollen May Trigger Urologic Chronic Pelvic Pain Flares
Pollen count increases associated with UCPPS flares in individuals who also have allergies or respiratory tract disorders
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
Allergists Affirm Safety of COVID-19 Vaccines for Most
All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol
Alaska HCW First in U.S. to Have Allergic Reaction to COVID-19 Vaccine
Worker felt flushed within 10 minutes of receiving vaccine, followed by shortness of breath and elevated heart rate
NHLBI Updates Guidance for Management of Asthma
Guidance focuses on tailored treatment interventions for specific age groups based on disease severity
